196 related articles for article (PubMed ID: 31378770)
1. Atorvastatin Blocks Advanced Glycation End Products Induced Reduction in Macrophage Cholesterol Efflux Mediated With ATP-Binding Cassette Transporters G 1.
Xu L; Wang YR; Li PC; Feng B
Circ J; 2019 Aug; 83(9):1954-1964. PubMed ID: 31378770
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end products increase lipids accumulation in macrophages through upregulation of receptor of advanced glycation end products: increasing uptake, esterification and decreasing efflux of cholesterol.
Xu L; Wang YR; Li PC; Feng B
Lipids Health Dis; 2016 Sep; 15(1):161. PubMed ID: 27644038
[TBL] [Abstract][Full Text] [Related]
3. HMG-CoA reductase inhibitors, simvastatin and atorvastatin, downregulate ABCG1-mediated cholesterol efflux in human macrophages.
Wang W; Song W; Wang Y; Chen L; Yan X
J Cardiovasc Pharmacol; 2013 Jul; 62(1):90-8. PubMed ID: 23846804
[TBL] [Abstract][Full Text] [Related]
4. Rosuvastatin blocks advanced glycation end products-elicited reduction of macrophage cholesterol efflux by suppressing NADPH oxidase activity via inhibition of geranylgeranylation of Rac-1.
Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
Horm Metab Res; 2011 Aug; 43(9):619-24. PubMed ID: 21823057
[TBL] [Abstract][Full Text] [Related]
5. RAGE Suppresses ABCG1-Mediated Macrophage Cholesterol Efflux in Diabetes.
Daffu G; Shen X; Senatus L; Thiagarajan D; Abedini A; Hurtado Del Pozo C; Rosario R; Song F; Friedman RA; Ramasamy R; Schmidt AM
Diabetes; 2015 Dec; 64(12):4046-60. PubMed ID: 26253613
[TBL] [Abstract][Full Text] [Related]
6. Homocysteine accelerates atherosclerosis via inhibiting LXRα-mediated ABCA1/ABCG1-dependent cholesterol efflux from macrophages.
Jin P; Bian Y; Wang K; Cong G; Yan R; Sha Y; Ma X; Zhou J; Yuan Z; Jia S
Life Sci; 2018 Dec; 214():41-50. PubMed ID: 30393020
[TBL] [Abstract][Full Text] [Related]
7. Heat shock protein 70 accelerates atherosclerosis by downregulating the expression of ABCA1 and ABCG1 through the JNK/Elk-1 pathway.
Zhao ZW; Zhang M; Chen LY; Gong D; Xia XD; Yu XH; Wang SQ; Ou X; Dai XY; Zheng XL; Zhang DW; Tang CK
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Aug; 1863(8):806-822. PubMed ID: 29678642
[TBL] [Abstract][Full Text] [Related]
8. CTRP12 ameliorates atherosclerosis by promoting cholesterol efflux and inhibiting inflammatory response via the miR-155-5p/LXRα pathway.
Wang G; Chen JJ; Deng WY; Ren K; Yin SH; Yu XH
Cell Death Dis; 2021 Mar; 12(3):254. PubMed ID: 33692340
[TBL] [Abstract][Full Text] [Related]
9. Human Lupus Plasma Pro-Atherogenic Effects on Cultured Macrophages Are Not Mitigated by Statin Therapy: A Mechanistic LAPS Substudy.
Reiss AB; Arain HA; Kasselman LJ; Renna HA; Zhen J; Voloshyna I; DeLeon J; Carsons SE; Petri M
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31438615
[No Abstract] [Full Text] [Related]
10. RAGE Mediates Cholesterol Efflux Impairment in Macrophages Caused by Human Advanced Glycated Albumin.
Machado-Lima A; López-Díez R; Iborra RT; Pinto RS; Daffu G; Shen X; Nakandakare ER; Machado UF; Corrêa-Giannella MLC; Schmidt AM; Passarelli M
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019603
[TBL] [Abstract][Full Text] [Related]
11. Astragalin Retards Atherosclerosis by Promoting Cholesterol Efflux and Inhibiting the Inflammatory Response via Upregulating ABCA1 and ABCG1 Expression in Macrophages.
Zhao ZW; Zhang M; Wang G; Zou J; Gao JH; Zhou L; Wan XJ; Zhang DW; Yu XH; Tang CK
J Cardiovasc Pharmacol; 2021 Feb; 77(2):217-227. PubMed ID: 33165140
[TBL] [Abstract][Full Text] [Related]
12. Angiopoietin-1 aggravates atherosclerosis by inhibiting cholesterol efflux and promoting inflammatory response.
Ou X; Gao JH; He LH; Yu XH; Wang G; Zou J; Zhao ZW; Zhang DW; Zhou ZJ; Tang CK
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Feb; 1865(2):158535. PubMed ID: 31678621
[TBL] [Abstract][Full Text] [Related]
13. Fargesin alleviates atherosclerosis by promoting reverse cholesterol transport and reducing inflammatory response.
Wang G; Gao JH; He LH; Yu XH; Zhao ZW; Zou J; Wen FJ; Zhou L; Wan XJ; Tang CK
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 May; 1865(5):158633. PubMed ID: 31988050
[TBL] [Abstract][Full Text] [Related]
14. Polydatin attenuates atherosclerosis in apolipoprotein E-deficient mice: Role of reverse cholesterol transport.
Peng Y; Xu J; Zeng Y; Chen L; Xu XL
Phytomedicine; 2019 Sep; 62():152935. PubMed ID: 31085374
[TBL] [Abstract][Full Text] [Related]
15. Sonodynamic therapy-induced foam cells apoptosis activates the phagocytic PPARγ-LXRα-ABCA1/ABCG1 pathway and promotes cholesterol efflux in advanced plaque.
Wang H; Yang Y; Sun X; Tian F; Guo S; Wang W; Tian Z; Jin H; Zhang Z; Tian Y
Theranostics; 2018; 8(18):4969-4984. PubMed ID: 30429880
[TBL] [Abstract][Full Text] [Related]
16. IL-22 is induced by S100/calgranulin and impairs cholesterol efflux in macrophages by downregulating ABCG1.
Chellan B; Yan L; Sontag TJ; Reardon CA; Hofmann Bowman MA
J Lipid Res; 2014 Mar; 55(3):443-54. PubMed ID: 24367046
[TBL] [Abstract][Full Text] [Related]
17. Leonurine Prevents Atherosclerosis Via Promoting the Expression of ABCA1 and ABCG1 in a Pparγ/Lxrα Signaling Pathway-Dependent Manner.
Jiang T; Ren K; Chen Q; Li H; Yao R; Hu H; Lv YC; Zhao GJ
Cell Physiol Biochem; 2017; 43(4):1703-1717. PubMed ID: 29045950
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin inhibits ABCA1 expression and cholesterol efflux in THP-1 macrophages by an LXR-dependent pathway.
Qiu G; Hill JS
J Cardiovasc Pharmacol; 2008 Apr; 51(4):388-95. PubMed ID: 18427282
[TBL] [Abstract][Full Text] [Related]
19. Effect of atorvastatin on AGEs-induced injury of cerebral cortex via inhibiting NADPH oxidase -NF-κB pathway in ApoE
Li Z; Yang P; Feng B
Mol Biol Rep; 2020 Dec; 47(12):9479-9488. PubMed ID: 33210255
[TBL] [Abstract][Full Text] [Related]
20. Atorvastatin improves plaque stability in diabetic atherosclerosis through the RAGE pathway.
Zhou F; Tan Y; Chen XH; Wu FL; Yang DJ; Zhang XW; Wu XM; Deng YQ
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):1142-1149. PubMed ID: 29509268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
